Saroja Pharma Industries India Limited (NSE: SAROJA)

SAROJA Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	8.78	8.78	10.61	11.4	7.31	1.61
Depreciation & Amortization	0.95	0.95	0.65	0.42	0.21	0.05
Other Amortization	-	-	0.01	0.04	0.02	-
Other Operating Activities	14.18	14.18	13.15	7.93	3.3	1.56
Change in Accounts Receivable	-51.32	-51.32	28.72	-67.56	-29.63	-28.88
Change in Inventory	34.68	34.68	-33.99	1.9	-3.89	-0.63
Change in Accounts Payable	-2.54	-2.54	5.58	11.55	13.97	16.01
Change in Other Net Operating Assets	5.53	5.53	-2.8	-2.41	-1.75	1.41
Operating Cash Flow	10.25	10.25	21.93	-36.74	-10.46	-8.86
Operating Cash Flow Growth	-53.27%	-53.27%	-	-	-	-
Capital Expenditures	-47.29	-47.29	-37.26	-3.02	-0.54	-0.23
Investment in Securities	-0.57	-0.57	-1.03	-0.37	-	-0.03
Other Investing Activities	0.24	0.24	0.13	0.1	0.04	0.01
Investing Cash Flow	-47.62	-47.62	-48.25	-3.35	-0.5	-0.24
Long-Term Debt Issued	-	-	40.5	31.21	13	12.36
Long-Term Debt Repaid	-44.54	-44.54	-	-	-	-
Net Debt Issued (Repaid)	-44.54	-44.54	40.5	31.21	13	12.36
Issuance of Common Stock	86.77	86.77	-	19.5	-	-
Other Financing Activities	-5.28	-5.28	-13.19	-8.01	-2.75	-2.64
Financing Cash Flow	36.95	36.95	27.31	42.7	10.26	9.72
Miscellaneous Cash Flow Adjustments	-	-	0	-	-	-
Net Cash Flow	-0.42	-0.42	1	2.61	-0.71	0.61
Free Cash Flow	-37.04	-37.04	-15.34	-39.76	-11.01	-9.09
Free Cash Flow Margin	-9.11%	-9.11%	-3.06%	-7.15%	-3.00%	-5.32%
Free Cash Flow Per Share	-10.50	-10.50	-5.22	-13.83	-4.05	-69.93
Cash Interest Paid	-	-	9.95	6.66	2.63	1.46
Cash Income Tax Paid	3.33	3.33	4.22	4.38	3	0.56
Levered Free Cash Flow	-53.67	-53.67	-28.35	-49.42	-14.18	-
Unlevered Free Cash Flow	-44.63	-44.63	-22.13	-45.26	-12.52	-
Change in Net Working Capital	13.66	13.66	2.49	56.53	20.65	-

Source: S&P Capital IQ. Standard template. Financial Sources.